.

MedImmune, Johns Hopkins Forge $6.5 Million Research Deal

Johns Hopkins: Joint research projects could develop new therapies for multiple sclerosis, cancer.

MedImmune and Johns Hopkins University have entered into a five-year, $6.5 million research partnership. FILE | Gaithersburg Patch
MedImmune and Johns Hopkins University have entered into a five-year, $6.5 million research partnership. FILE | Gaithersburg Patch

Gaithersburg-based MedImmune and Johns Hopkins University have entered into a five-year, $6.5 million research partnership, the company announced Wednesday. 

The collaboration will result in joint research projects focused on a broad range of diseases, including cardiovascular and metabolic diseases, oncology, and neuroscience, a spokeswoman for MedImmune said.

“We are excited about the opportunity for our scientists to collaborate with MedImmune researchers to accelerate the development of new therapies to treat a variety of serious diseases such as multiple sclerosis, rheumatoid arthritis, chronic obstructive pulmonary disease and certain types of cancer,” said Dr. Landon King, executive vice dean of Johns Hopkins University School of Medicine, in an emailed news release. “We believe that by working together to leverage the strengths of each organization, we can make significant advances.”

A spokeswoman for MedImmune said the company would contribute at least $5.3 million over the first three years, and that Johns Hopkins would provide the additional resources and project support.   

This initiative is one of several regional collaborations by MedImmune. 

In September, the company announced a five-year, $6 million research deal with University of Maryland, Baltimore.

Boards

More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something
See more »